tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market
Advertisement

Clal Biotech (CBI) Income Statement

Compare
0 Followers

Clal Biotech Income Statement

Last quarter (Q2 2025), Clal Biotech's total revenue was 0.00, a decrease of ― from the same quarter last year. In Q2, Clal Biotech's net income was -5.17M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
433.00K 104.00K 370.00K 224.00K 206.00K
Gross Profit
-183.00K 104.00K 370.00K 224.00K 206.00K
Operating Expenses
6.34M 10.29M 12.27M 77.47M 10.30M
Depreciation and Amortization
283.00K 526.00K 17.64M 22.51M 23.87M
EBITDA
-6.34M -24.02M 64.22M -55.08M 13.23M
Operating Income
-6.34M -10.18M -27.42M -77.59M 40.15M
Other Income/Expenses
-68.73M -17.91M -13.61M 11.00M 9.68M
Pretax Income
-75.07M -28.09M -41.02M -66.59M 49.84M
Net Income
-62.46M -31.05M -61.74M -89.58M 109.03M
Per Share Metrics
Basic EPS
-0.40 -0.20 -0.39 -0.57 0.68
Diluted EPS
-0.40 -0.20 -0.39 -0.57 0.68
Weighted Average Shares Outstanding
158.44M 156.85M 156.85M 158.44M 161.24M
Weighted Average Shares Outstanding (Diluted)
158.44M 156.85M 156.85M 158.44M 161.24M
Currency in ILS

Clal Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis